Trials / Completed
CompletedNCT02538562
Human Epidermal Growth Factor Receptor 2 (HER2) Advanced Gastric Epidemiology Study in Korea
HER2 Advanced Gastric Epidemiology Study in Korea: An Assessment of HER2 Status in Tumor Tissue Samples of Gastric and Gastro-esophageal (GE) Junction Cancer
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,695 (actual)
- Sponsor
- Hoffmann-La Roche · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This study is designed to gather epidemiological data in Korea on HER2 incidence in gastric and gastroesophageal junction cancer as assessed by local laboratories in a real-life setting. No investigational products will be provided or evaluated.
Conditions
Timeline
- Start date
- 2011-10-11
- Primary completion
- 2013-04-19
- Completion
- 2013-04-19
- First posted
- 2015-09-02
- Last updated
- 2017-07-11
Locations
14 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02538562. Inclusion in this directory is not an endorsement.